Kalivir Immunotherapeutics Inc

Kalivir Immunotherapeutics, Inc. develops biotechnology solutions focused on oncolytic viral immunotherapy for cancer treatment. The company enters licensing and partnership agreements, conducts clinical trials, and advances global development of novel therapies. Kalivir serves biopharmaceutical companies and healthcare providers in APAC, Europe, and the US.